ResearcherKTH Royal Institute of TechnologyActive in the last 2 years

Johan Nilvebrant

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6104-6446; OpenAlex author ID A5073512740. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 1 paper

Papers 1

An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo. Co-author DOI 10.1016/j.tranon.2025.102512 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Béla Bozóky · 1 shared paper, 2025 · strength 0.20
- Paper An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor ta… DOI 10.1016/j.tranon.2025.102512 ↗
Carlos Fernández Moro · 1 shared paper, 2025 · strength 0.20
- Paper An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor ta… DOI 10.1016/j.tranon.2025.102512 ↗
Tímea Szekerczés · 1 shared paper, 2025 · strength 0.20
- Paper An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor ta… DOI 10.1016/j.tranon.2025.102512 ↗
Arun Kumar Selvam · 1 shared paper, 2025 · strength 0.20
- Paper An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor ta… DOI 10.1016/j.tranon.2025.102512 ↗
Mikael Björnstedt · 1 shared paper, 2025 · strength 0.20
- Paper An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor ta… DOI 10.1016/j.tranon.2025.102512 ↗
Per‐Åke Nygren · 1 shared paper, 2025 · strength 0.20
- Paper An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor ta… DOI 10.1016/j.tranon.2025.102512 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.